Oncotype DX® – presentations during the conference “Staškovy dny“ on targeted breast cancer therapy

On April 3, a press conference was held in the Faust House in Prague, Charles Square on the occasion of the oncology congress called “Staškovy dny“. “Less is sometimes more...“ was the motto of the press conference and of the entire professional event. The possibility of testing patients with early breast cancer using the genetic assay Oncotype DX®, which may help to reduce the number of patients sometimes undergoing chemotherapy without the necessary benefit, was presented by Prof. MUDr. Luboš Petruželka, CSc., chair of the Department of Oncology of the General University Hospital and the First Faculty of Medicine, Charles University, in the section on news in targeted breast cancer therapy.

On April 5, during the oncology congress called “Staškovy dny“ at TOP Hotel Prague, Role of Oncotype DX® in personalized management of breast cancer was presented by the invited lecturer, Dr. M. Thill, Ph.D. of Agaplesion Markus Krankenhaus of Frankfurt am Mein. Dr. Thill shared his positive experience in the use of Oncotype DX® assays in his decision-making process on breast cancer therapy in patients of his hospital.

Presentation of Oncotype DX®